drugset / Trial / NCT00832546

A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers

NCT00832546 ↗

Phase 1 Completed 18 enrolled TorreyPines Therapeutics
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine the effects of NGX426 on intradermal capsaicin induced pain in hyperalgesia.

Timeline

Start
2008-05
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject NGX426 Small molecule — Oral

Indications

No indication recorded.